Interdyscyplinary management of verrucous carcinoma in renal transplant recipient on long term immunosuppression. Clinical report.

[1]  S. Kjaer,et al.  Human papillomavirus‐related anogenital premalignancies and cancer in renal transplant recipients: A Danish nationwide, registry‐based cohort study , 2020, International journal of cancer.

[2]  G. Reid,et al.  Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice , 2019, Clinical transplantation.

[3]  A. Neu,et al.  Immunogenicity of Human Papillomavirus Recombinant Vaccine in Children with CKD. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[4]  P. Fiedor,et al.  Human papillomavirus-related verrucous carcinoma in a renal transplant patient after long-term immunosuppression: a case report. , 2014, Transplantation proceedings.

[5]  U. Beuers,et al.  Receptors, cells and circuits involved in pruritus of systemic disorders. , 2014, Biochimica et biophysica acta.

[6]  T. Todo,et al.  Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population , 2014, Cancer science.

[7]  Deepali Kumar,et al.  Immunogenicity of Quadrivalent Human Papillomavirus Vaccine in Organ Transplant Recipients , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  J. Morrow,et al.  Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients. , 2010, Mitochondrion.

[9]  A. Toland,et al.  Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. , 2009, The Journal of investigative dermatology.

[10]  G. Murphy,et al.  The impact of skin disease following renal transplantation on quality of life , 2005, The British journal of dermatology.

[11]  J. McGregor,et al.  Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. , 2005, The Journal of investigative dermatology.